Meng Yuan

Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder

F. Shi, Ye Liu, Huiming Zhang, 2021, Frontiers in Immunology.

Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder

F. Shi, Ye Liu, Huiming Zhang, 2021, Therapeutic advances in neurological disorders.

Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study

F. Shi, H. Gu, Zixiao Li, 2020, The Lancet regional health. Western Pacific.

B-Cell Compartmental Features and Molecular Basis for Therapy in Autoimmune Disease

F. Shi, Yongjun Wang, Qiang Liu, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial

Chunshui Yu, F. Shi, J. Bennett, 2020, The Lancet Neurology.

Incidence of multiple sclerosis in China: A nationwide hospital-based study

F. Shi, Yongjun Wang, H. Gu, 2020, The Lancet regional health. Western Pacific.

Group 2 innate lymphoid cells resolve neuroinflammation following cerebral ischaemia

Minshu Li, Wei-Na Jin, Qiang Liu, 2023, Stroke and vascular neurology.

Corrigendum to ‘Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study’

F. Shi, H. Gu, Zixiao Li, 2021, The Lancet regional health. Western Pacific.